Nearmedic's Subsidiary Matriflex Receives Its First Invention Patent

Nearmedic's Subsidiary Matriflex Receives Its First Invention Patent

RF patent No. 2665962 «BIORESORBABLE BIOLOGICAL MATRIX FOR FILLING-IN BONE DEFECTS AND METHOD FOR ITS PRODUCTION» was issued by the Federal Service for Intellectual Property (Rospatent) on September 5, 2018.

The patent was obtained in the framework of one of the projects of Nearmedic’s Regenerative Medicine platform and serves as the basis for the line of osteoplastic materials BoneGraft MATRIX and BoneGraft COLLAGEN. BoneGraft products are based on the original technology of biological material processing, which makes it possible to obtain highly purified biological matrices for bone tissue regeneration and to neutralize all risks of their use for patients, including immune reactions and the risk of infection. At the same time, both the three-dimensional structure of the tissue and the properties of the native natural material are preserved.

The company plans to develop its portfolio and launches the procedure of international patenting. This particular project enjoys support on the part of the SKOLKOVO Foundation.